Home Editorial
Editorial standards

Who writes this, and how it is checked

Every article on this site is published under one masthead, the Bacillus F Research Desk. This page says plainly who that is, what it is qualified to say and how a page gets reviewed before it ships.

The Bacillus F Research Desk

The byline on every article here reads Bacillus F Research Desk. That is the editorial function of Bacillus F OÜ: the small team inside the company that reads the source documents and writes what they support. It is a collective masthead, not a person's name, on purpose.

The reason is the same rule that governs the whole site: we do not manufacture trust signals. Inventing a staff scientist with a doctorate and a headshot would make these pages look more authoritative without making a single sentence in them more true. What we can offer is the provenance of the claims, and that is what this page documents.

What the desk is qualified to do is narrow and specific: read a patent, a genome deposit record, a published paper and a comet-assay report, and restate what they say without inflating it. What the desk is not qualified to do is practise medicine, interpret your bloodwork, or tell you what a supplement will do to your body. You will not find that here, because we will not write it.

Where the expertise actually comes from

The primary research behind Bacillus F was done by our scientific partners. The strain was recovered during permafrost core drilling at Mammoth Mountain, Yakutia, and the research program that followed was led by Prof. Anatoli Brouchkov, a geocryologist at Moscow State University, with collaborators across microbiology, genomics and gerontology.

The product was developed together with Prof. Brouchkov and his group, and we work as one team. The scientific claims on this site are theirs and are cited to their patents and publications; the commercial writing is ours. Where a sentence is ours rather than theirs, we do not dress it up as science.

Our own first-hand experience is commercial and operational rather than academic, and it is real: we handle the strain's documentation pack, deal with the manufacturer, run the batch and shipping process, and answer the questions buyers actually ask. Where an article draws on that (batch sizes, what the paperwork contains, how the drops arrive, what customs does with them) it is written from direct experience. Where an article draws on the science, it is written from documents, and the documents are published openly on the Science page so you can check us.

How an article is reviewed before it ships

  • Sourcing. Every factual claim must trace to a document in the archive (a patent, the genome deposit, the comet-assay report) or to published third-party literature that is named in the text.
  • Claim review. A human reads the draft against those sources line by line. Anything that outruns the source is cut, not softened.
  • Compliance pass. No diagnosis, treatment, cure or prevention language. No lifespan-extension claim. No implied clinical trial in humans; there are none to cite.
  • Dating. Published and updated dates on the byline are real, and the same values feed the article's structured data, so the visible date and the marked-up date cannot drift apart.
  • Correction. If we get something wrong we fix the page itself and move the update date. We do not quietly delete the article.

The note under every byline, "Reviewed against the patent & assay record", is a description of this process, not decoration.

Corrections and contact

If you find a claim on this site that the documents do not support, write to info@bacillusf.com and say which page and which sentence. We reply in writing within 48 hours, and if you are right the page changes.

For the company itself (legal entity, how we operate, what we refuse to claim) see About. For the documents themselves, see Science.

Check us against the archive

Patents, genome deposit, the published paper, comet-assay imaging, in full.

Open the evidenceRead the articles